Sahitya Mallipeddi
Rheumatology · Plainfield, INNPI 1962667535
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 548 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by Amgen at 33.7% of the total.
Across 548 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$1K
- Pfizer$680
- Novartis$632
- E.r. Squibb & Sons, L.L.C.$614
- AstraZeneca$437
- plus $2K from 20 others
What the payments were for
- Food & beverage$8,74799%
- Education$581%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 198 | $2,965 |
| AbbVie | 84 | $1,378 |
| Pfizer | 55 | $680 |
| Novartis | 52 | $632 |
| E.r. Squibb & Sons, L.L.C. | 28 | $614 |
| AstraZeneca(2 entities) | 23 | $437 |
| Johnson & Johnson | 23 | $429 |
| UCB, Inc. | 21 | $385 |
| Lilly USA, LLC | 16 | $292 |
| Sanofi | 7 | $176 |
| ANI Pharmaceuticals, Inc. | 6 | $155 |
| GSK | 9 | $137 |
| Genentech USA, Inc. | 3 | $65 |
| Bristol Myers Squibb | 4 | $65 |
| Progentec Diagnostics, Inc. | 1 | $58 |
| Mallinckrodt Hospital Products Inc. | 2 | $55 |
| Kowa Pharmaceuticals America, Inc. | 3 | $55 |
| Mallinckrodt Enterprises LLC | 3 | $53 |
| Aurinia Pharma U.S., Inc. | 2 | $41 |
| Novo Nordisk | 2 | $26 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
| Sobi, Inc | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Medexus Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolia$104
How this compares
$8,805 in reported general payments places this provider in the 75th percentile of 106 rheumatology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 18 | $390 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Plainfield
- Anna GramlingPlainfield$12K
- David BattIndianapolis$577K
- Kathleen ThomasNoblesville$511K
- Keith ReichDyer$193K
- Douglas SmithIndianapolis$147K
- Ahmad SalahMerrillville$139K
- Inna AroutiounovaIndianapolis$102K
- James CohenIndianapolis$76K
- Nina RamessarFort Wayne$75K
- Anita ZachariahMunster$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.